<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101671285</journal-id>
<journal-id journal-id-type="pubmed-jr-id">44575</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry Cogn Neurosci Neuroimaging</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol Psychiatry Cogn Neurosci Neuroimaging</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry. Cognitive neuroscience and neuroimaging</journal-title>
</journal-title-group>
<issn pub-type="epub">2451-9030</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28730183</article-id>
<article-id pub-id-type="pmc">5512437</article-id>
<article-id pub-id-type="doi">10.1016/j.bpsc.2016.07.002</article-id>
<article-id pub-id-type="manuscript">NIHMS817990</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Aberrant cerebellar connectivity in bipolar disorder with psychosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Shinn</surname>
<given-names>Ann K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roh</surname>
<given-names>Youkyung S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ravichandran</surname>
<given-names>Caitlin T.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>Justin T.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Öngür</surname>
<given-names>Dost</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cohen</surname>
<given-names>Bruce M.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Schizophrenia and Bipolar Disorder Program, McLean Hospital, Belmont, MA, USA</aff>
<aff id="A2">
<label>2</label>Program for Neuropsychiatric Research, McLean Hospital, Belmont, MA, USA</aff>
<aff id="A3">
<label>3</label>Lurie Center for Autism, Massachusetts General Hospital for Children, Boston, MA, USA</aff>
<aff id="A4">
<label>4</label>Department of Psychiatry, Harvard Medical School, Boston, MA, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label><bold>Corresponding Author:</bold> Ann K. Shinn, MD, MPH, 115 Mill Street, Mailstop 108, Belmont, MA 02478, USA, Tel: 617-855-3053, Fax: 617-855-2895, <email>akshinn@partners.org</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p>
<bold>Financial Disclosures</bold>
</p>
<p>Dr. Öngür reports having received research support from Roche Genentech in 2014. All other authors report no biomedical financial interests or potential conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2018</year>
</pub-date>
<volume>2</volume>
<issue>5</issue>
<fpage>438</fpage>
<lpage>448</lpage>
<!--elocation-id from pubmed: 10.1016/j.bpsc.2016.07.002-->
<self-uri xlink:href="http://www.sciencedirect.com/science/article/pii/S2451902216300763?via%3Dihub"></self-uri>
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">The cerebellum, which modulates affect and cognition in addition to motor functions, may contribute substantially to the pathophysiology of mood and psychotic disorders, such as bipolar disorder. A growing literature points to cerebellar abnormalities in bipolar disorder. However, no studies have investigated the topographic representations of resting state cerebellar networks in bipolar disorder, specifically their functional connectivity to cerebral cortical networks.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">Using a well-defined cerebral cortical parcellation scheme as functional connectivity seeds, we compared ten cerebellar resting state networks in 49 patients with bipolar disorder and a lifetime history of psychotic features and 55 healthy control participants matched for age, sex, and image signal-to-noise ratio.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Patients with psychotic bipolar disorder showed reduced cerebro-cerebellar functional connectivity in somatomotor A, ventral attention, salience, and frontoparietal control A and B networks relative to healthy control participants. These findings were not significantly correlated with current symptoms.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">Patients with psychotic bipolar disorder showed evidence of cerebro-cerebellar dysconnectivity in selective networks. These disease-related changes were substantial and not explained by medication exposure or substance use. Therefore, they may be mechanistically relevant to the underlying susceptibility to mood dysregulation and psychosis. Cerebellar mechanisms deserve further exploration in psychiatric conditions, and this study’s findings may have value in guiding future studies on pathophysiology and treatment of mood and psychotic disorders, in particular.</p>
</sec>
</abstract>
<kwd-group>
<kwd>cerebellum</kwd>
<kwd>bipolar disorder</kwd>
<kwd>psychosis</kwd>
<kwd>functional connectivity</kwd>
<kwd>networks</kwd>
<kwd>resting state</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>